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Diffuse alveolar hemorrhage (DAH) can be caused by several etiologies including vasculitis, drug exposure, anticoagulants,
infections, mitral valve stenosis, and regurgitation. Chronic mitral valve regurgitation (MR) has been well documented as an
etiological factor forDAH, but there have been only a few caseswhich have reported acutemitral valve regurgitation as an etiology of
DAH.Acutemitral valve regurgitation can be a life-threatening condition and often requires urgent intervention. In rare cases, acute
mitral regurgitation may result in a regurgitant jet which is directed towards the right upper pulmonary vein and may specifically
cause right-sided pulmonary edema and right-sided DAH. Surgical repair of the mitral valve results in rapid resolution of DAH.
Acute MR should be considered as a possible etiology in patients presenting with unilateral pulmonary edema, hemoptysis, and
DAH.
1. Introduction
Hemoptysis can be caused by lesions that are localized in the
airway, lungs or by widespread lesions in the lungs. Diffuse
alveolar hemorrhage (DAH) is characterized by widespread
bleeding into the alveoli due tomicrovascular injury [1]. DAH
may also be accompanied by pulmonary edema.The resultant
impediment of gas exchange is thought to cause dyspnea.
Whereas most patients present with bilateral involvement,
unilateral involvement is rare. Cardiogenic unilateral pul-
monary edema is a rare clinical entity that presents with
diagnostic challenges. Most cases occur in the upper right
side and are caused by severe mitral regurgitation [2, 3]. It
is associated with an independent increased risk of mortality
due to possible delay in diagnosis and underestimation of
the severity of mitral regurgitation (MR). Cardiogenic uni-
lateral pulmonary edema is more common on the right side
for several reasons. The direction of the mitral regurgitation
jet predominantly affects the upper right pulmonary vein and
causes a larger increase in mean capillary pressure on the
right side. This may consequently result in a greater degree
of right acute pulmonary edema.
Patients with DAH usually present with dyspnea and
diffuse alveolar infiltrates noted on imaging. Many etiolo-
gies such as drug exposure (penicillamine, propylthiouracil,
ketorolac, etc.), cocaine smoking, pulmonary embolism,
sarcoidosis, vasculitis, and mitral stenosis have been docu-
mented to cause DAH [4–8]. However, acute mitral regur-
gitation (MR) has rarely been reported as an etiology for
DAH [9–13]. Cardiac etiologies of DAH seem to act through
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mechanical pressure rather than by inflammation of the
capillaries as seen in most other causes of DAH. Diffuse alve-
olar hemorrhage is diagnosed by sequential bronchoalveolar
lavage revealing increasing hemorrhagic lavage returns.
2. Case Description
A 57-year-old Chinese male with a past medical history
significant for hypertension, hyperlipidemia, and moder-
ate mitral regurgitation secondary to mitral valve prolapse
presented with a 3-week history of progressive hemoptysis
and worsening dyspnea. The symptoms started insidiously
and progressed to a point where his exercise tolerance was
reduced to a few steps. He was a plumber by profession
and a lifetime nonsmoker. He denied wheezing, fever, night
sweats, chest pain, and weight loss. He had no history of
hemoptysis or bleeding from any other body sites. He did not
use anymedications and denied recent travel or sick contacts.
On physical examination, he appeared to be in moderate
respiratory distress, tachycardia, and tachypnea. His vital
signs were blood pressure of 146/80mmHg, heart rate of
116/min, respiratory rate of 34/min, temperature of 99.1 F, and
saturating at 96% on 3 liters of oxygen by nasal cannula. He
was oriented to time place and person and was found to be
using his accessorymuscles of respiration.His chest examina-
tion was notable for coarse crackles on the right side without
any wheezing. His cardiac examination revealed tachycardia
with a 3/6 pansystolic murmur best heard over the mitral
area. The rest of his physical examination was unremarkable.
His extremities were perfusing well and no peripheral edema
was noted. His labs were notable for leukocytosis with neu-
trophilia (WBC: 12.7 k/mm3; neutrophils: 84%; eosinophils
< 1%), his electrolytes were within normal range, and renal
function was deranged with elevated blood urea nitrogen
(BUN) and creatinine (Na: 143mEq/L; K: 4.6mEq/L; Cl:
107mEq/L; HCO
3
: 23mEq/L; BUN: 40mg/dL; creatinine:
1.5mg/dL). His liver function tests (LFTs) were notable for
elevated liver enzymes (AST: 48U/L; ALT: 127U/L). His
arterial blood gas (ABG) was notable for a pH of 7.44, pCO
2
of 31mmHg, and a pO
2
of 84mmHg. His chest X-ray (CXR)
showed right sided fluffy infiltrates (Figure 1(a)). He was
admitted to the medical floor and started on ceftriaxone and
azithromycin for presumed community acquired pneumo-
nia. However, his respiratory status deteriorated and he was
transferred to the Cardiac Intensive Care Unit where he was
started on noninvasive mechanical ventilation (inspiratory
pressure of 15mmHg, expiratory pressure of 8mmHg at 100%
oxygen supplementation). An ABG showed a pH of 7.13,
pCO
2
of 64mmHg, and a pO
2
of 68mmHg indicative of
acute respiratory acidosis. His respiratory condition contin-
ued to deteriorate and he was intubated and mechanically
ventilated with a positive end expiratory pressure (PEEP)
of 5mmHg and 50% oxygen supplementation. The patient’s
CXR revealed infiltrates which were more dense and conflu-
ent (Figure 1(b)). His labs were significant for up-trending
leukocytosis (15 k/mm3). The patient’s blood and urine cul-
tures were negative. Tests for legionella, mycoplasma, HIV,
and influenza were also negative. Autoimmune and vasculitis
panels [antinuclear antibody (ANA), antineutrophil cyto-
plasmic antibodies (ANCA), and antiglomerular basement
membrane antibody (GBM)] tests were negative. An ABG
after commencing mechanical ventilation showed a pH of
7.44, pCO
2
of 31mmHg, and a pO
2
of 81mmHg. Computed
tomography (CT) of his chest confirmed the presence of
dense infiltrates predominantly located in the right upper
and middle lobes (Figures 1(c) and 1(d)). Transthoracic
echocardiogram showed an ejection fraction (EF) of 70%,
mildly dilated left atrium, significant prolapse of the posterior
mitral leaflet, and moderate tricuspid regurgitation. Right
heart catheterization showed a pulmonary artery pressure
of 56/23/35mmHg (systolic/diastolic/mean); pulmonary cap-
illary wedge pressure (PCWP) of 22mmHg, right atrial
pressure of 4mmHg, RV: 53/6mmHg (systolic/diastolic);
cardiac Index (by thermo dilution) of 2.1 liters/min/m2, and a
pulmonary artery resistance of 9 wood units. Bronchoscopy
revealed fresh blood in all the lobes with no obvious
source and no endobronchial lesions. Sequential lavage from
the right middle lobe was not progressively bloodier and
hence less consistent with diffuse alveolar hemorrhage. Bron-
choalveolar lavage was negative for cytology, acid fast bacillus
(AFB), fungal stain, and pneumocystis carinii pneumonia
(PCP). Thoracentesis yielded 150 cc of serous fluid with a
pH of 7.6, LDH of 80U/L, protein of 0.9 g/dL, glucose of
120mg/dL, cell countwith a differential of 55%of neutrophils,
lymphocytes of 25%, and mesothelial cells of 10%. This was
consistent with a transudative pleural effusion. The cytology
and culture results of the fluid from thoracentesis were also
negative. A transesophageal echocardiogram (TEE) showed
thickening and elongation of the anterior leaflet of the mitral
valve consistent with myxomatous degeneration, up to 1 cm
in thickness at the margin of the anterior leaflet, prolapse
of posterior leaflet into left atrium, aneurysm measuring 1 ×
1.6 cm2 and perforation into left atrium and severe mitral
regurgitation but no vegetations. The patient continued to
have increased oxygen requirements and persistent hemop-
tysis and eventually underwent an emergent mitral valve
repair. Perioperative TEE revealed hypertrophied right and
left ventricles, normal right and left ventricular function with
EF of 55%, mild anteroseptal wall hypokinesis, prolapse of
the posterior mitral leaflet with a flail P3 segment, and severe
mitral regurgitation with systolic flow reversal in right upper
pulmonary vein (Figures 2(a) and 2(b)). A final diagnosis
of alveolar hemorrhage secondary to severe acute mitral
regurgitation frommyxomatous degeneration of mitral valve
was made. Notably, his hemoglobin had decreased from
14.5 gm/dL to 11.7 gm/dL. Postoperative TEEdid not show any
evidence of mitral valve regurgitation (Figure 2(c)). A repeat
bronchoscopy 3 days after the mitral valve repair showed
clearing of the alveolar hemorrhage (Figures 3(a), 3(b), and
3(c)).The patient rapidly recovered thereafter as was reflected
in his CXR (Figure 4).
3. Discussion
Acute mitral regurgitation may occur as a result of four
principal reasons: (1) a flail leaflet due tomyxomatous disease,
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(a) (b)
(c) (d)
Figure 1: (a) CXR showing right sided fluffy infiltrates during the initial presentation. (b) CXR showing aworsening of infiltrates accompanied
by pulmonary edema. (c) and (d) Sagittal and transverse chest CT sections confirming the presence of dense infiltrates predominantly located
in the right upper and middle lobes.
(a) (b) (c)
Figure 2: (a) and (b) Perioperative TEE revealing a perforated posterior leaflet (red arrow) and regurgitant flow directed towards the right
side (green arrow). (c) Postoperative TEE showing no evidence of mitral valve regurgitation.
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(a) (b) (c)
Figure 3: (a), (b), and (c): Repeat bronchoscopy 3 days after the mitral valve repair showing clearing of the alveolar hemorrhage in all lobes
of the right lung.
Figure 4: CXR after a few weeks of mitral valve repair showing
clearing of the infiltrates.
infective endocarditis, trauma, and so forth; (2) chordae
tendineae rupture due to trauma, spontaneous rupture, infec-
tive endocarditis, and acute rheumatic fever; (3) papillary
muscle rupture or displacement due to acute myocardial
infarction or severe ischemia or trauma; (4) dysfunctional
prosthetic valve due to degeneration, impaired closure, and
paravalvular leak. Acute mitral regurgitation may present
as cardiogenic shock and warrant urgent intervention [14].
There are several possible reasons for the development of
DAH in acute mitral valve regurgitation. Hemodynamic
changes in acuteMR aremore severe than in chronicMR.The
degree of hemodynamic deterioration in acute MR depends
upon the etiology and the degree of MR, but generally there
is a lack of time for the left atrium and left ventricle to adapt.
The normal left atrium is not compliant and the sudden and
marked increase in left atrial volume in acute MR results in
an abrupt elevation in pressure within the left atrium. This is
immediately reflected back into the pulmonary circulation,
often leading to pulmonary edema. TEE findings in patients
with acute MR show that the regurgitant jet is directed at
the right pulmonary venous system and that the velocity of
flow and the pressure gradient is much greater at the orifice
of the right pulmonary venous system compared with the
left [15]. Transthoracic echocardiography may not provide
accurate information about regurgitant volume and orifice
area in acute MR when compared to chronic MR [16–18].
In some patients, DAH may present as a diffuse area of
confluent ground glass opacity with sparing of the peripheral
parenchyma, often referred to as “window frame” effect [11].
Chronic extravasation of blood from the capillaries due to
conditions like chronic mitral stenosis (MS) can result in
hemosiderosis and eventually pulmonary ossification [19,
20]. The case described here illustrates the varied mani-
festations of acute MR and the importance of considering
acuteMR as an etiology of DAH. Diagnostic procedures such
as transesophageal echocardiography may help in an early
diagnosis and assist in the decision to consider surgery as an
early intervention.
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